| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-15 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate |
1987-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5f89e7a16603f9b3a29436d6516cbf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6482f6ff63088cf78576cc4a58ff5edf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e865e210da4ec1f2d4f4200cd86ff029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38009e464a8ea85f62f8c1e27263e36e |
| publicationDate |
1988-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0253143-A2 |
| titleOfInvention |
Pharmaceutical compositions for suppository |
| abstract |
A pharmaceutical composition for suppository which comprises buprenorphine or its pharmaceutically acceptable acid added salt as the active ingredient and a mixed base composed of 70 to 95 wt.% of polyethylene glycol with average molecular weight of 200 to 20,000 and 30 to 5 wt.% of propylene glycol. |
| priorityDate |
1986-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |